BIMEDA DE MÉXICO, S.A. DE C.V.

What BIMEDA DE MÉXICO, S.A. DE C.V. does

Bimeda de México, S.A. de C.V. is the Mexican operating subsidiary of Ireland-headquartered Bimeda Animal Health Limited, distributing a comprehensive veterinary pharmaceutical portfolio across Mexico from its headquarters in Santiago de Querétaro. The company serves bovine, porcine, equine, ovine, caprine, and poultry producers alongside companion animal (dog and cat) owners and veterinarians. Its Mexican operations are sales- and marketing-led, with approximately 20+ employees focused on commercial distribution of products developed and manufactured by the broader Bimeda group's nine global facilities in Ireland, the UK, the USA, Canada, France, China, Brazil, and Argentina.

The product portfolio spans multiple therapeutic categories: endectocides (the Bimectin family of ivermectin-based parasiticides in injectable, pour-on, long-acting, and oral paste formulations); antibiotics (beta-lactams, tetracyclines, sulfonamides, lincosamides, ceftiofur); anti-inflammatories and steroids; joint supplements; intramammary products (Multimast DC); nutritional supplements (vitamins, electrolytes, minerals, iron dextran for piglets); nutraceuticals and immunomodulators; and specialty items such as continuous-release soluble glass boluses for trace mineral supplementation (Cosecure, Coseicure) and a patented long-acting selenium suspension (Selenate L.A.). Underlying manufacturing capabilities — accessed via the parent group — include sterile injectable production at 400L-10,000L batch scale, oral paste filling handling viscosities of 50,000-400,000 cps, and proprietary continuous-release ruminal bolus technology.

The business model is direct distribution of registered veterinary pharmaceutical products (each carrying a SENASA-style Q-registration number) to veterinarians, livestock producers, and animal health professionals nationwide in Mexico. Revenue is generated through one-time product sales across therapeutic categories, with the Mexican subsidiary leveraging the parent group's regulatory approvals from FDA, EMA, and SENASA, its global brand built over 50+ years, and dedicated marketing channels including a corporate website, Facebook presence, and product webinars targeting veterinarians and animal health professionals.

Name

BIMEDA DE MÉXICO, S.A. DE C.V.

Legal name

Bimeda de México S.A. de C.V.

Website

https://bimeda.mx

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

11–50 employees

Short description

Bimeda de México is the Mexican sales-and-marketing subsidiary of Ireland-based Bimeda Animal Health Limited, distributing a broad veterinary pharmaceutical portfolio — including the Bimectin endectocide family, antibiotics, anti-inflammatories, and companion animal nutraceuticals — to veterinarians, livestock producers, and pet owners across Mexico from its Querétaro headquarters.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Other Animal Food Manufacturing (311119)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Antimicrobials & Anti-infectives (HLAMAEAE), Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG), Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Livestock medications
• Companion animal health
• Veterinary drugs

Headquarters

HQ city

Santiago de Querétaro

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceutical Product Sales: Bimeda generates revenue through the manufacture and distribution of veterinary pharmaceutical products including antibiotics, anti-inflammatory drugs, parasiticides, intramammary products, vitamins, minerals, hormones, and nutraceuticals for livestock and companion animals. Products are sold through direct distribution channels in Mexico and through the company's global network.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

BIMEDA DE MÉXICO manufactures and distributes a comprehensive range of veterinary pharmaceutical products for livestock (cattle, pigs, sheep, horses) and companion animals. The portfolio spans antibiotics, anti-inflammatories, vitamins and nutritional supplements, parasiticides, reproductive hormones, antidiarrheals, topical antiseptics, and specialty formulations delivered in multiple dosage forms including sterile injectables, oral pastes, boluses, suspensions, powders, and topical sprays.

Product overview

Bimeda de México is a veterinary pharmaceutical company offering a comprehensive portfolio of animal health products across multiple therapeutic categories. The product portfolio includes the Bimectin family of endectocides (pasta, injectable, LA, Pour-On, Plus, MAX-H) for parasite control in cattle, horses, and pigs; antibiotics including beta-lactams (Bimoxyl L.A., Pro-Pen-G), tetracyclines (Tetroxy-LA, Tetroxy-HCA), and other classes (Bimotrim CO, Linxmed-SP, Neomed 325, Solucef PPU); anti-inflammatory/NSAID products (Flunazine, Dexium, Dexium-SP, Butatron); joint supplements for companion animals (Polychews + Krill, Condrovet Force HA, Polyglycan, Polyglycan HV); intramammary products (Multimast DC); nutritional supplements (FerroForte, Cal Mag-K, Bovitrace Extra, Selenate L.A., Cosecure, Coseicure); mineral boluses; probiotics (Pro-Enteric); immunomodulators (Impromune); urinary health products (Calmurofel); antiseptics (Coppersept); disinfectants (Bio-Safe); and specialty products including oxytocin, Sustain III Calf, and SpectoGard Scour-Chek. The company serves the bovine, porcine, equine, ovine, caprine, poultry, and companion animal sectors.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Products distributed and used in over 80 countries globally
• +1 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Zjpharma (Rainbowlabs Joint Venture)coreStrategic or Co-development PartnerRainbowlabs is a center for raw material testing and innovation built by Bimeda. It is a joint venture between Bimeda and Zjpharma, approved by European authorities and FDA. The facility provides technical and R&D services, laboratory testing, GMP audits, and high-quality technical services to Bimeda.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Vetoquinol: Independent French veterinary pharmaceutical company with a comparable product portfolio covering parasiticides, anti-infectives, anti-inflammatories, joint health, and nutraceuticals for livestock and pets. Direct competitor of similar size and structure.
• Norbrook Laboratories: UK/Ireland-based privately held veterinary pharmaceutical manufacturer producing antibiotics, anti-inflammatories, parasiticides and companion animal products. Closest peer to Bimeda in terms of family-owned structure, multi-species portfolio, and geographic spread.
• Ceva Santé Animale: French global animal health company specializing in pharmaceuticals, vaccines, and equipment for livestock and companion animals. Comparable mid-sized direct peer competing in similar product categories including parasiticides, anti-infectives, and reproductive products.
• Dechra Pharmaceuticals: UK-based veterinary pharmaceutical company specializing in companion animal and livestock products including parasiticides, NSAIDs, antibiotics and dermatology. Comparable specialty pharma peer with overlapping product categories in joint health, dermatology, and endocrinology.
• Virbac: France-based global veterinary pharmaceutical company with similar multi-species product breadth (parasiticides, antibiotics, anti-inflammatories, dermatology, nutraceuticals). Closest direct peer to Bimeda in terms of portfolio mix and scale, competing across livestock and companion animals in Mexico and Latin America.
• Phibro Animal Health: U.S.-listed animal health company focused on livestock pharmaceuticals, nutritional specialty products, and vaccines. Comparable peer competing in Mexican livestock market with mineral nutrition and anti-infective products similar to Bimeda's nutritional supplement range.

Broad incumbents

• MSD Animal Health: Animal health division of Merck offering vaccines, parasiticides, anti-infectives and pharmaceuticals across all major species. Direct competitor to Bimeda de México across livestock and companion animal therapeutics with substantially larger global R&D and local Mexican field force.
• Elanco Animal Health: Global animal health company (including the former Bayer Animal Health portfolio) competing in livestock pharmaceuticals, parasiticides, and companion animal therapeutics. Major competitor to Bimeda in the Mexican market with deeper pockets and broader brand recognition.
• Zoetis: World's largest animal health company offering pharmaceuticals, vaccines, diagnostics and nutraceuticals across livestock and companion animals. Direct competitor to Bimeda's full portfolio in Mexico, but with significantly larger scale, broader portfolio, and deeper local presence.
• Boehringer Ingelheim Animal Health: One of the largest animal health companies globally with a strong vaccines and pharmaceuticals portfolio across livestock and companion animals. Direct competitor in Mexico with established local presence and broader R&D investment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Bimeda-de-M%C3%A9xico-244158005638674
• LinkedInlinkedin.com/company/bimeda-de-m%C3%A9xico-s.a.-de-c.v.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIMEDA DE MÉXICO, S.A. DE C.V.